AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,947,000 | +57.5% | 233,067 | -26.1% | 7.82% | +131.1% |
Q3 2019 | $8,858,000 | -25.8% | 315,331 | 0.0% | 3.38% | -13.6% |
Q2 2019 | $11,938,000 | -3.0% | 315,331 | 0.0% | 3.92% | +22.2% |
Q1 2019 | $12,304,000 | +83.0% | 315,331 | 0.0% | 3.20% | +45.1% |
Q4 2018 | $6,723,000 | -46.1% | 315,331 | 0.0% | 2.21% | -19.9% |
Q3 2018 | $12,484,000 | +3.6% | 315,331 | 0.0% | 2.76% | +6.2% |
Q2 2018 | $12,049,000 | +27.2% | 315,331 | 0.0% | 2.60% | +25.7% |
Q1 2018 | $9,476,000 | +735.6% | 315,331 | +373.8% | 2.06% | +374.7% |
Q1 2017 | $1,134,000 | -6.7% | 66,553 | 0.0% | 0.44% | -17.6% |
Q4 2016 | $1,216,000 | +2.6% | 66,553 | 0.0% | 0.53% | -4.7% |
Q3 2016 | $1,185,000 | – | 66,553 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |